Subscribe to RSS
DOI: 10.1055/s-2008-1078426
Synthesis of New Cyclopropanated Tryptamine Analogues
Publication History
Publication Date:
16 May 2008 (online)
Abstract
A series of tryptamine analogues bearing a cyclopropylamine unit was prepared, starting from 3-indolyl acetonitriles, through a MeTi(Oi-Pr)3-mediated cyclopropanation.
Key words
cyclopropanes - indoles - titanium - transition metals - tryptamines
-
1a
Vilsmaier E. In The Chemistry of the Cyclopropyl GroupRappoport Z. Wiley; New York: 1987. p.1341 -
1b
Houben-Weyl
Vol. E17a-c:
de Meijere A. Thieme; Stuttgart: 1997. -
2a
Suckling CJ. Angew. Chem., Int. Ed. Engl. 1988, 27: 537 -
2b
Salaün J. Top. Curr. Chem. 2000, 207: 1 -
3a
Wise R.Andrews JM.Edwards LJ. Antimicrob. Agents Chemother. 1983, 23: 559 -
3b
Todo Y.Nitta J.Miyajima M.Fukuoka Y.Yamashiro Y.Nishida N.Saikawa I.Narita H. Chem. Pharm. Bull. 1994, 42: 2063 -
3c
Brighty KE.Castaldi MJ. Synlett 1996, 1097 -
3d
Högberg M.Sahlberg C.Engelhardt P.Noréen R.Kangasmetsä J.Johansson NG.Öberg B.Vrang L.Zhang H.Sahlberg B.-L.Unge T.Lövgren S.Fridborg K.Bäckbro K. J. Med. Chem. 1999, 42: 4150 -
3e
Daluge SM.Martin MT.Sickles BR.Livingston DA. Nucleosides Nucleotides 2000, 19: 297 -
3f
Tichenor MS.MacMillan KS.Stover JS.Wolkenberg SE.Pavani MG.Zanella L.Zaid AN.Spalluto G.Rayl TJ.Hwang I.Baraldi PG.Boger DL. J. Am. Chem. Soc. 2007, 129: 14092 ; and references therein -
4a
Fujita T. J. Med. Chem. 1973, 16: 923 -
4b
N-Cyclopropyltryptamine was also described as a potent monoamine oxidase inhibitor. See:
Winn M.Horrom BW.Rasmussen RR.Chappell EB.Plotnikoff NP. J. Med. Chem. 1975, 18: 437 - 5
Shimamoto K.Ishida M.Shinozaki H.Ohfune Y. J. Org. Chem. 1991, 56: 4167 - 6
Vangveragong S.Kanthasamy A.Lucaites VL.Nelson DL.Nichols DE. J. Med. Chem. 1998, 41: 4995 - 7
Tsotinis A.Vlachou M.Papahatjis DP.Calogeropoulou T.Nikas SP.Garratt PJ.Piccio V.Vonhoff S.Davidson K.Teh M.-T.Sugden D. J. Med. Chem. 2006, 49: 3509 - 8
Raoul M.Patigny D.Fabis F.Dauphin F.Rault S.Sapi J.Laronze J.-Y. J. Enzym. Inhib. Med. Chem. 2006, 251 -
9a
Glennon RA. J. Med. Chem. 2003, 46: 2795 -
9b
Holenz J.Mercè R.Diaz JL.Guitart X.Codony X.Dordal A.Romero G.Torrens A.Mas J.Andaluz B.Hernandez S.Monroy X.Sanchez E.Hernandez E.Pérez R.Cubi R.Sanfeliu O.Bushchmann H. J. Med. Chem. 2005, 48: 1781 - 10
Sapi J.Grébille Y.Laronze J.-Y.Lévy J. Synthesis 1992, 383 -
11a
Bertus P.Szymoniak J. Chem. Commun. 2001, 1792 -
11b For a review, see:
Bertus P.Szymoniak J. Synlett 2007, 1346 - An alternative approach involving the titanium-mediated cyclopropanation of N,N-dialkylamides should be envisioned, but requires the preparation of the amides. For the reaction, see:
-
12a
Chaplinski V.de Meijere A. Angew. Chem., Int. Ed. Engl. 1996, 35: 413 -
12b
de Meijere A.Kozhushkov SI.Savchenko AI. J. Organomet. Chem. 2004, 689: 2033 - For related applications, see:
-
12c
Cao B.Xiao D.Joullié MM. Org. Lett. 1999, 1: 1799 -
12d
Ouhamou N.Six Y. Org. Biomol. Chem. 2003, 1: 3007 -
12e
Gensini M.de Meijere A. Chem. Eur. J. 2004, 10: 785 -
12f
Larquetoux L.Kowalska JA.Six Y. Eur. J. Org. Chem. 2004, 3517 -
12g
Larquetoux L.Ouhamou N.Chiaroni A.Six Y. Eur. J. Org. Chem. 2005, 4654 -
12h
Faler CA.Joullié MM. Org. Lett. 2007, 9: 1987 -
13a
Laroche C.Behr JB.Szymoniak J.Bertus P.Plantier-Royon R. Eur. J. Org. Chem. 2005, 5084 -
13b
Laroche C.Plantier-Royon R.Szymoniak J.Bertus P.Behr J.-B. Synlett 2006, 223 -
13c
Pearson M.Plantier-Royon R.Szymoniak J.Bertus P.Behr JB. Synthesis 2007, 3589 - 15
Bertus P.Szymoniak J. Org. Lett. 2007, 9: 659 - 16
Chaplinski V.Winsel H.Kordes M.de Meijere A. Synlett 1997, 111 - 20
Street LJ.Baker R.Castro JL.Chambers MS.Guiblin AR.Hobbs SC.Matassa VG.Reeve AJ.Beer MS.Middlemiss DN.Noble AJ.Stanton JA.Scholey K.Hargreaves RJ. J. Med. Chem. 1993, 36: 1529
References and Notes
The ketone by-product might also be obtained by the hydrolysis of metallacycle B (Scheme [2] ). This assumption was ruled out by deuterolysis of the reaction media (no trace of deuterium was observed on the methyl moiety).
17General Procedure for the MeTi(O i -Pr) 3 -Mediated Cyclopropanation of Nitriles 10a-c and 11a,b (Table 1): To a solution of the nitrile (1 mmol) and MeTi(Oi-Pr)3 (1.5 mmol) in THF (10 mL) was added dropwise under argon the Grignard reagent (1.5 mmol). The yellow solution darkened gradually within 5 min. After stirring for 1.5 h, BF3·OEt2 was added (2 mmol). After 30 min, the dark mixture was quenched with 1 M HCl (10 mL). EtOAc (20 mL) was added, followed by 3 M NaOH (10 mL). The mixture was stirred until the blue aqueous solution become white. The aqueous phase was extracted with EtOAc (2 × 20 mL). After drying (MgSO4) and evaporation of the solvents, the crude material was purified by flash chromatography (EtOAc).
18Selected data: 1-[(1-Benzenesulfonyl-1 H -indol-3-yl)methyl]cyclopropylamine (12a): pale yellow solid; mp 97-98 °C. IR (neat): 3385, 1447, 1361, 1175 cm-1. 1H NMR (250 MHz, CDCl3): δ = 0.46-0.63 (m, 4 H), 1.50 (br s, 2 H, NH2), 2.72 (s, 2 H), 7.13-7.47 (m, 7 H), 7.78 (d, J = 7.7 Hz, 2 H), 7.94 (d, J = 8.3 Hz, 1 H). 13C NMR (63 MHz, CDCl3): δ = 14.5, 33.7, 35.7, 113.7, 119.8, 120.8, 123.2, 123.7, 124.7, 126.5, 129.1, 131.3, 133.7, 135.2, 137.9. HRMS (ES): m/z [M + H]+ calcd for C18H19N2O2S 327.1167; found: 327.1169.
19The cyclopropanation of unprotected 8 gave only a low yield of the primary cyclopropylamine.
21Selected data: N , N -Dimethyl-1-[(1-benzenesulfonyl-1 H -indol-3-yl)methyl]cyclopropylamine (6a): yellow oil. IR (neat): 3365, 2916, 2845, 1634, 1445, 1264, 1119 cm-1. 1H NMR (300 MHz, CDCl3): d = 0.25-0.57 (m, 4 H), 2.45 (s, 6 H), 3.01 (s, 2 H), 7.25-7.52 (m, 7 H), 7.80-7.83 (m, 2 H), 7.98 (d, J = 8.1 Hz, 1 H). 13C NMR (75 MHz, CDCl3): d = 13.3, 21.1, 40.9, 43.7, 113.9, 119.6, 120.3, 123.3, 124.2, 124.7, 126.5, 129.1, 131.7, 133.7, 135.1, 138.0. HRMS (EI): m/z [M+·] calcd for C20H22N2O2S: 354.1402; found: 354.1398. N , N -Dimethyl-1-[(1-methyl-2-vinyl-1 H -indol-3-yl)methyl]cyclopropylamine (7a): yellow oil. IR (neat): 3054, 2986, 2845, 1628, 1437, 1262 cm-1. 1H NMR (300 MHz, CDCl3): d = 0.30-0.55 (m, 4 H), 2.63 (s, 6 H), 3.30 (s, 2 H), 3.70 (s, 3 H), 5.50 (dd, J = 1.2, 11.9 Hz, 1 H), 5.69 (dd, J = 1.2, 17.9 Hz, 1 H), 7.07 (dd, J = 11.9, 17.9 Hz, 1 H), 7.02-7.38 (m, 3 H), 7.54 (d, J = 7.4 Hz, 1 H). 13C NMR (75 MHz, CDCl3): d = 12.2, 18.6, 30.7, 40.4, 44.7, 109.1, 117.3, 118.9, 119.3, 122.1, 125.9, 128.6, 128.7, 135.2, 137.2. HRMS (ES): m/z [M + H+] calcd for C17H23N2: 255.1861; found: 255.1855.